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Each of a range of pharmacological agents which function to increase intracellular levels of CAMP caused a morpholog- 
ical ‘differentiation’ of neuroblastoma x glioma hybrid, NGlOS-15, cells grown in tissue culture. Associated with this 
differentiation, increased incorporation of P’P]ADP-ribose catalysed by pertussis toxin was noted into a band of some 
3940 kDa in membranes derived from these cells. lmmunoblotting using two antipeptide antisera which identify different 
regions of G,a demonstrated marked increases in the levels of this polypeptide in membranes of the differentiated cells. 
However, levels of the b-subunit did not increase appreciably with differentiation. 
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1. INTRODUCTION 
The neuroblastoma x glioma hybrid cell line, 
NG108-15, is a widely used model system in neuro- 
biology [ 11. Reasons for the enduring popularity of 
these cells include the fact that they are electrically 
excitable and they express a wide range of receptors 
for neurotransmitters and hormones which are 
coupled to a number of distinct second messenger 
effector systems and ion channels [l]. Dependent 
upon the nature of the experiments performed 
upon these cells, they are used in either an ‘undif- 
ferentiated’ [2,3] or ‘differentiated’ [3,4] state in 
which the cells extend numerous neurite-like pro- 
cesses. Differentiation is usually achieved by in- 
cubation of the cells in tissue culture with various 
agents which, as a common mode of action, elevate 
intracellular levels of CAMP. 
The function of a number of the receptors on 
these cells, including both S-opioid and 
az-adrenergic receptors, is attenuated by prior ex- 
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posure of the cells to pertussis toxin [5,6]. This tox- 
in functions by catalysing an NAD-dependent 
ADP-ribosylation of certain G-proteins (71. This 
modification prevents productive coupling between 
the G-protein and relevant receptors. As NG108-15 
cells express a number of different pertussis toxin- 
sensitive G-proteins [2,3], attempts have been 
made to characterize the molecular identity of the 
G-protein(s) with which specific receptors interact. 
Using membranes derived from undifferentiated 
NG108-15 cells, McKenzie et al. [2] concluded that 
the signal from the 6-opioid receptor was transduc- 
ed only by Gi. In contrast, Hescheler et al. [4], us- 
ing differentiated NG108-15 cells, concluded that 
information from the d-opioid receptor was trans- 
duced preferentially via G,. In an attempt to in- 
vestigate further this apparent dichotomy, we have 
assessed potential alterations in levels of G, which 
might occur with CAMP-induced differentiation in 
NG108-15 cells. We demonstrate that a range of 
treatments which increase the effective intracellular 
concentration of CAMP in these cells and hence 
produce differentiation also markedly increase 
levels of the a-subunit of G,. 
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2. MATERIALS AND METHODS 
2.1. Tissue culture 
Control, untreated neuroblastoma x glioma hybrid, 
NG108-15, cells were grown in tissue culture as described [2,3] 
except that the concentration of foetal calf serum (Gibco, 
Paisley, Scotland) was 2% (v/v). In the production of differen- 
tiated cells, they were maintained as above but with the addition 
and maintenance of either dibutyryl CAMP (1 mM), I-bromo 
CAMP (1 mM), forskolin (10 PM) or prostaglandin Ei (10 PM) 
for 6 days prior to cell harvest. Cell pastes from each of these 
treatments were maintained at -80°C before membrane 
preparation [8]. The membranes o produced were stored at 
- 80°C until use. 
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Pertussis toxin (Porton Products, Porton Down, England) 
catalysed ADP-ribosylation of membranes of these cells was 
performed with [32P]NAD (New England Nuclear) as in [2]. 
Protein was estimated by the method of Lowry et al. [9] using 
bovine serum albumin as standard. 
2.2. Immunological analysis - 25 
GM was detected immunologically using two distinct antipep- 
tide antisera. Antiserum IMl was generated in a rabbit against 
an antigen produced by coupling a synthetic peptide (NLKEDGI 
SAAKDVK), corresponding to amino acids 22-35 of Ciocu, to 
keyhole limpet haemocyanin, with glutaraldehyde, as we have 
previously described [IO]. This antiserum is specific for Ci& 
[ Ill. Antiserum OCl was produced by a similar strategy against 
a synthetic peptide (ANNLRGCGLY) which corresponds to the 
C-terminal decapeptide of GN. It is also specific for C&r [7]. 
Antiserum BNl was produced in a similar fashion against the 
peptide MSELDQLRQE, which represents the N-terminal deca- 
peptide of the,f?i-subunit of G-proteins. The methodology of the 
immunoblotting protocols used in these experiments has been 
described in detail [2,3,10,18]. 
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Fig. 1. Pertussis toxin-catalysed ADP-ribosylation of mem- 
branes of untreated and dibutyryl CAMP differentiated 
NG108-15 cells. Membranes (25 fig) of untreated (A,B) or 
dibutyryl CAMP (1 mM, 6 days) (C) NGlOS-15 cells were ADP- 
ribosylated with [32P]NAD in the absence (A) or presence (B,C) 
of thiol-activated pertussis toxin, as described in section 2 and in 
[al. 
3 RESULTS 
Membranes derived from either untreated or di- 
butyryl cyclic AMP differentiated neuroblastoma 
x glioma NG108-15 cells were treated with thiol- 
preactivated pertussis toxin and (32P]NAD and 
resolved on an SDS-polyacrylamide gel (12.5070, 
v/v, acrylamide). In each case, apparently two 
polypeptides of estimated h4, 39000 and 40000 
(fig.1) were labelled in the presence of pertussis 
toxin. These are likely to represent he a-subunits 
of G, and Gi, respectively. Whilst relatively little 
difference was noted in the incorporation of radio- 
activity into the 40 kDa polypeptide in either the 
untreated or differentiated membranes, a marked 
increase of incorporation .was noted in the 39 kDa 
polypeptide in membranes of the dibutyryl CAMP 
differentiated cells compared to membranes of un- 
treated cells (fig.1). In the undifferentiated cells 
only some 5% of radioactivity from the pertussis 
toxin-catalysed ADP-ribosylation was incor- 
porated into the 39 kDa polypeptide (G,). How- 
ever, in the differentiated membranes, in a series of 
experiments, 25-50070 of the radioactivity was 
found in G,. 
To ascertain whether the observed increase in 
pertussis toxin-catalysed ADP-ribosylation was in- 
deed in response to differentiation mediated by 
CAMP and not to the presence of butyrate, we 
treated NGlOS-15 cells with a range of phar- 
macological agents which increase intracellular 
levels of CAMP. Growth of NG108-15 cells in the 
presence of each of prostaglandin Ei (10 pm), for- 
skolin (10 PM) and 8-bromo CAMP (1 mM) pro- 
duced a similar morphological differentiation of 
the cells to that with dibutyryl CAMP (1 mM) (not 
shown). Pertussis toxin-catalysed ADP-ribosyla- 
tion of membranes of each cell preparation demon- 
strated markedly elevated incorporation of 
radioactivity into the 39-40 kDa region. Estima- 
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tion of the radioactivity incorporated into the com- 
bination of these polypeptides, by excision of the 
relevant area of th?!.gel and scintillation counting, 
demonstrated that differentiation of the cells pro- 
duced an approx. 2-3-fold increase (table 1). 
Pertussis toxin-catalysed ADP-ribosylation of 
G-proteins can be modulated by a range of factors 
other than the absolute levels of the c-subunits of 
the G-proteins present in the membranes. We thus 
performed Western blot analysis of membranes 
derived from untreated and cyclic AMP differen- 
tiated NGl08-15 cells with an antipeptide anti- 
serum (OCl) which identifies the extreme C- 
terminus of the cr-subunit of G,. In membranes 
derived from either untreated cells or cells grown in 
the presence of any of the agents employed, anti- 
serum OCl identified an apparently single poly- 
peptide of 39 kDa (fig.2). No matter which phar- 
macological agent was used for the cellular dif- 
ferentiation process, markedly increased levels of 
Table 1 
Pertussis toxin-catalysed ADP-ribosylation of membranes of 
untreated and CAMP-differentiated NG108-15 cells 
Treatment [32P]ADP-ribose % of cpm 
incorporated into in untreated 
39 + 40 kDa band membranes 
(cpm) 
Expt 1 
Untreated 
Dibutyryl CAMP (1 mM) 
Forskolin (10 hM) 
912+ 22 100 
2215 f 236 243 
1804 +_ 160 198 
Expt 2 
Untreated 504* 22 100 
Prostaglandin Er (10rM) 1212* 30 276 
8-Bromo CAMP (1 mM) 1393+ 26 240 
NG108-15 cells were maintained for 6 days in the absence or 
presence of agents which elevate intracellular CAMP levels, as 
detailed in section 2. Membranes (25 pg) derived from these cells 
were prepared and treated with thiol-activated pertussis toxin 
and [3zP]NAD as in section 2. The samples were then alkylated 
with N-ethyl maleimide [18] resolved by SDS-PAGE (lo%, v/v, 
acrylamide) and autoradiographed. The autoradiograph so 
generated was used as a template to locate the radioactivity at 
approx. 40 kDa, which was excised from the dried gel and deter- 
mined by liquid scintillation counting. No radioactivity was in- 
corporated into polypeptides of this approximate size in the 
absence of pertussis toxin. Data for the cpm are means + SE 
(n = 4). Data represent incorporation of radioactivity into a 
combination of Gi (40 kDa) and G, (39 kDa) as it is not possible 
to separate these polypeptides ufficiently well to allow the exci- 
sion of bands comprising solely one or the other 
Fig.2. Immunoblotting of membranes of untreated and CAMP- 
differentiated NG108-15 cells to detect Cd with antiserum 
OCI. Membranes (100/g) of untreated (A,D) and CAMP- 
differentiated NG108-15 (B,C,E,F) cells were resolved by SDS- 
PAGE, transferred to nitrocellulose and immunoblotted using 
antiserum OC1 (1: 5000 dilution) as the primary agent. Lanes: 
(B) cells differentiated with dibutyryl CAMP (1 mM); (C) with 
forskolin (10~M); (E) with I-bromo CAMP (1 mM); (F) with 
prostaglandin El (10 PM). Similar results were seen in 3 further 
experiments. 
G& were identified in the cell membranes by this 
antiserum. As it was possible that cellular differen- 
tiation was associated with a modification close to 
the C-terminus of G& that increased the interac- 
tion of the polypeptide with the anti-G, antibodies 
in antiserum OCl, we repeated the experiments 
with a second antiserum (IMl) which identifies a 
peptide sequence present close to the N-terminus of 
Gd. Identical results were obtained with the sec- 
ond antiserum (fig.3) thus confirming the presence 
of markedly elevated levels of G& associated with 
CAMP-mediated differentiation of NGl08-15 cells. 
As G-proteins are usually considered to exist as 
heterotrimeric complexes of cy + P/y subunits we 
examined whether levels of the &subunit were in- 
creased in parallel with G& upon CAMP-induced 
differentiation of the cells. Using an antipeptide 
antiserum (BNl), directed against the extreme N- 
terminus of the ,&I polypeptide, we identified a 
single polypeptide of 36 kDa in membranes of 
NG108-15 cells. However, we noted only a small 
increase in levels of this polypeptide caused by any 
of the differentiation procedures employed (fig.4). 
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Fig.3. lmmunoblotting of membranes of untreated and CAMP- 
differentiated NG108-15 cells to detect Cd with antiserum IMl. 
Details of this experiment are as recorded in the legend to fig.2 
except hat the primary antiserum was a 1: 200 dilution of IMl. 
Lanes: (A,D) untreated cells; (B) cells treated with 8-bromo 
CAMP (1 mM); (C) with prostaglandin Er (10/M); (E) with 
dibutyryl CAMP (1 mM); (F) with forskolin (10 hM). The same 
pattern of immunoreactivity was observed in three other ex- 
periments. 
M, (x10-~) 
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Fig.4. Immunoblotting of membranes of untreated and CAMP- 
differentiated NG108-15 cells with antiserum BNl to detect fi- 
subunit. Details of this experiment are as recorded in the legend 
to fig.2 except hat the primary antiserum was a 1: 200 dilution 
of BNl. A single band of 36 kDa was observed in all samples, 
with only minor variations in intensity of the staining. Cells dif- 
ferentiated with: (A) dibutyryl CAMP (1 mM), (B) forskolin 
(lO@M), (C) undifferentiated cells, (D) 8-bromo CAMP 
(1 mM), (E) prostaglandin Er (1OyM). 
4. DISCUSSION 
A number of G-proteins which can act as sub- 
strates for pertussis toxin-catalysed ADP- 
ribosylation have been identified, both from pro- 
tein purification schemes [12] and via analysis of 
cDNA clones [ 131. These G-proteins display ex- 
treme homology in their primary sequence and as 
such, questions have been posed as to whether the 
individual proteins function to transfer informa- 
tion between different receptors and effector 
systems or whether they are essentially isoforms of 
one another. Reconstitution of purified fractions 
of Gi and Go, generally isolated from brain which 
expresses high levels of both proteins, with a varie- 
ty of purified or partially purified receptor species 
in artificial systems, has frequently suggested that 
Gi and G, display similar abilities to interact with a 
particular receptor [14,15]. Whilst these ex- 
periments demonstrate that the individual G- 
proteins do not appear to display a high degree of 
selectivity in receptor recognition, such investiga- 
tions do not allude to whether more specific inter- 
actions occur in membrane or whole cell systems. 
The neuroblastoma x glioma hybrid cell line 
NGlO&15 is a suitable model with which to address 
questions of this nature as it represents a homo- 
geneous cell population and is known to express 
both G, and a subtype of Gi [3,16]. Further, it ex- 
presses a 6-opioid receptor which interacts with a 
G-protein(s) which is sensitive to treatment with 
pertussis toxin [5,6]. 
Dependent upon the nature of the experiments to 
be performed, these cells are grown in either the 
absence or presence of an agent which elevates in- 
tracellular CAMP. This treatment produces a mor- 
phological differentiation of the cells [ 11. In mem- 
branes from untreated NG108-15 cells, the opioid 
peptides cause inhibition of adenylate cyclase ac- 
tivity [ 171. McKenzie et al. [2,20] have 
demonstrated that the interaction of the opioid 
receptor with the G-protein signalling system, as 
assessed by measuring enkephalin-stimulation of 
high-affinity GTPase activity, is essentially com- 
pletely attenuated by antibodies directed against 
the extreme C-terminus of Gia [lo]. In contrast an- 
tibodies which identify the equivalent region of 
G& have no effect. These data argue strongly that 
in membranes of the untreated cells the entire 
opioid receptor signal is transduced via Gi. How- 
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ever, as well as causing inhibition of adenylate 
cyclase, opioid peptides reduce Ca2+ currents 
across membranes of NG108-15 cells [4]. This pro- 
cess can, however, only be observed in CAMP- 
differentiated cells. Using this approach, Hescheler 
et al. [4] have observed a reconstitution of opioid 
peptide-mediated reduction in Ca2+ currents in 
pertussis toxin-pretreated ifferentiated cells by the 
addition of G,. This process could be mimicked, 
but not as effectively, by a purified preparation of 
Gi. 
The potential dichotomy between these two 
observations, although they are not strictly com- 
parable, has led us to examine what happens to the 
levels of G, during CAMP-mediated differentiation 
of NG108-15 cells. By performing pertussis toxin- 
catalysed ADP-ribosylation of membranes of both 
untreated and dibutyryl CAMP-differentiated cells 
and resolving the 39 kDa G, and 50 kDa Gi (fig. l), 
we noted that radioactivity incorporated into the 
39 kDa polypeptide was markedly increased in the 
differentiated membranes in comparison to the un- 
treated membranes. By contrast, little alteration in 
labelling of the 40 kDa polypeptide was noted 
under the two conditions. Further, the relative 
labelling of 39 to 40 kDa polypeptides in the mem- 
branes from untreated cells was small, presumably 
indicating that the absolute amount of Go was very 
low in comparison to Gi. 
As a series of factors, including the state of 
association of CY and ,6/y subunits and the presence 
or absence of various nucleotides, are known to 
modulate the rate of pertussis toxin-catalysed 
ADP-ribosylation of relevant G-proteins [ 18,191, 
we then endeavoured to confirm that the increased 
incorporation of radioactivity into the 39 kDa 
polypeptide in the differentiated membranes was 
indeed a reflection of elevated amounts of G&. 
For these experiments we used either of two anti- 
peptide antisera, which we have generated [8,11], 
which display specificity for this polypeptide. One 
of these (OCl) identifies the extreme C-terminus of 
GN, the other (IMI) a region close to the N- 
terminus. Western blotting with either of these an- 
tisera confirmed the presence of markedly elevated 
levels of Gd in the differentiated membranes. This 
was the case, irrespective of the pharmacological 
manipulation used to induce the differentiation 
(figs 2,3). 
Based on these observations, the suggestion 
[2,20] that in membranes of undifferentiated 
NG108-15 essentially all of the 6-opioid receptor- 
mediated GTPase activity is at the level of Gi may 
well reflect the fact that very little Go is present. As 
such, this low level of G, would provide very little 
GTPase activity, even if it were also coupled to the 
opioid receptor. As it is not possible to measure 
Ca2+ currents successfully in untreated NGl08-15 
cells, then an assessment of the role of G, in these 
cells in controlling this process is not feasible. It 
may however be that opioid peptide-mediated in- 
hibition of adenylate cyclase is transduced via Gi in 
NGl08-15 cells whilst the effects of the same 
agonists on Ca2+ currents are transduced via G,. 
Experiments using C-terminal Gi and G, antisera 
to attempt o uncouple opioid receptor modulation 
of Ca2+ currents in differentiated NG108-15 cells 
are likely to be useful in assessing this possibility. 
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